The ongoing Ebola outbreak in West Africa has resulted in fast-track development of vaccine candidates. We tested a vesicular stomatitis virus vector expressing Ebola virus glycoprotein for safety in pigs. Inoculation did not cause disease and vaccine virus shedding was minimal, which indicated that the vaccine virus does not pose a risk of dissemination in pigs.
CITATION STYLE
De Wit, E., Marzi, A., Bushmaker, T., Brining, D., Scott, D., Richt, J. A., … Feldmann, H. (2015). Safety of recombinant VSV-Ebola virus vaccine vector in pigs. Emerging Infectious Diseases, 21(4), 702–704. https://doi.org/10.3201/eid2104.142012
Mendeley helps you to discover research relevant for your work.